First Tracks Biotherapeutics: closes private placement of 6,106,870 shares

What happened First Tracks Biotherapeutics, Inc. reported that on Oct 19, 2026 it closed its previously announced private placement of an aggregate 6,106,870 shares of the company’s common stock, par value $0.001 per share, and entered into a registration rights agreement with the investors in the private placement.

Key details

• Closing date: Oct 19, 2026. Shares issued: 6,106,870 common shares, par value $0.001 per share.
• Under the registration rights agreement, the company is required to file or confidentially submit a registration statement with the SEC covering resale of the shares no later than 30 days following the Closing Date.
• The registration rights agreement is filed as Exhibit 10.1 to the Form 8-K; certain portions are redacted pursuant to Item 601(b)(2)(ii) and Item 601(b)(10)(iv) of Regulation S-K, and omitted schedules/exhibits are omitted pursuant to Item 601(a)(5) of Regulation S-K. The company will furnish unredacted copies or omitted schedules/exhibits to the SEC upon request.

Why it may matter This Form 8-K reports Item 1.01 (entry into a material definitive agreement—the registration rights agreement) and Item 9.01 (exhibits filing). This filing does not show why the insider traded or why the company acted.